Medpace Historical Balance Sheet

MEDP Stock

USD 324.51 6.08 1.84%

Trend analysis of Medpace Holdings balance sheet accounts such as Other Current Liab of 1.1 B provides information on Medpace Holdings' total assets, liabilities, and equity, which is the actual value of Medpace Holdings to its prevalent stockholders. By breaking down trends over time using Medpace Holdings balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Medpace Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medpace Holdings is a good buy for the upcoming year.

Medpace Holdings Inventory

0.86

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

About Medpace Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Medpace Holdings at a specified time, usually calculated after every quarter, six months, or one year. Medpace Holdings Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Medpace Holdings and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Medpace currently owns. An asset can also be divided into two categories, current and non-current.

Medpace Holdings Balance Sheet Chart

At this time, Medpace Holdings' Cash And Short Term Investments are relatively stable compared to the past year. As of 03/26/2025, Common Stock Total Equity is likely to grow to about 279.2 K, while Total Stockholder Equity is likely to drop slightly above 677.5 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Medpace Holdings assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Medpace Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Medpace Holdings' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Medpace Holdings current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.At this time, Medpace Holdings' Cash And Short Term Investments are relatively stable compared to the past year. As of 03/26/2025, Common Stock Total Equity is likely to grow to about 279.2 K, while Total Stockholder Equity is likely to drop slightly above 677.5 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	188.9M	142.1M	126.2M	167.3M
Total Assets	1.4B	1.7B	2.1B	1.4B

Short Long Term Debt Total Total Assets

Medpace Holdings balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets
Common Stock Shares Outstanding		-0.5	0.24	-0.67	-0.69	-0.13	0.24	0.18	-0.46	-0.69	0.46	0.24	-0.41	-0.55	-0.58	-0.53	-0.45	0.3	-0.55	-0.53	0.61	0.51	0.33	0.21	0.33	-0.27
Total Assets	-0.5		-0.51	0.73	0.84	0.63	-0.35	0.25	0.88	0.85	-0.77	0.09	0.76	0.82	0.73	0.86	0.72	-0.52	0.82	0.85	-0.47	-0.44	-0.45	-0.43	-0.45	0.82
Short Long Term Debt Total	0.24	-0.51		-0.4	-0.64	-0.79	0.79	-0.78	-0.69	-0.64	0.84	-0.06	-0.86	-0.51	0.07	-0.62	-0.61	0.98	-0.51	-0.73	0.35	-0.3	0.78	0.99	0.78	-0.72
Other Current Liab	-0.67	0.73	-0.4		0.87	0.43	-0.43	-0.06	0.56	0.86	-0.77	0.0	0.55	0.9	0.6	0.58	0.63	-0.45	0.9	0.62	-0.93	-0.59	-0.36	-0.36	-0.36	0.48
Total Current Liabilities	-0.69	0.84	-0.64	0.87		0.5	-0.56	0.17	0.85	1.0	-0.84	-0.2	0.84	0.82	0.64	0.87	0.79	-0.69	0.82	0.89	-0.74	-0.49	-0.56	-0.6	-0.56	0.71
Total Stockholder Equity	-0.13	0.63	-0.79	0.43	0.5		-0.6	0.82	0.58	0.52	-0.87	0.61	0.63	0.72	0.01	0.44	0.55	-0.74	0.72	0.52	-0.37	0.26	-0.6	-0.73	-0.6	0.8
Other Liab	0.24	-0.35	0.79	-0.43	-0.56	-0.6		-0.57	-0.49	-0.56	0.72	0.05	-0.65	-0.44	0.14	-0.5	-0.36	0.86	-0.44	-0.56	0.43	-0.28	0.59	0.85	0.59	-0.52
Net Tangible Assets	0.18	0.25	-0.78	-0.06	0.17	0.82	-0.57		0.44	0.2	-0.57	0.45	0.54	0.26	-0.34	0.26	0.37	-0.73	0.26	0.34	0.06	0.63	-0.57	-0.77	-0.57	0.69
Property Plant And Equipment Net	-0.46	0.88	-0.69	0.56	0.85	0.58	-0.49	0.44		0.87	-0.74	-0.16	0.94	0.64	0.6	0.95	0.84	-0.72	0.64	0.95	-0.33	-0.26	-0.58	-0.65	-0.59	0.91
Current Deferred Revenue	-0.69	0.85	-0.64	0.86	1.0	0.52	-0.56	0.2	0.87		-0.84	-0.18	0.85	0.82	0.65	0.88	0.79	-0.7	0.82	0.91	-0.72	-0.48	-0.56	-0.61	-0.57	0.73
Net Debt	0.46	-0.77	0.84	-0.77	-0.84	-0.87	0.72	-0.57	-0.74	-0.84		-0.26	-0.81	-0.89	-0.27	-0.68	-0.73	0.85	-0.89	-0.76	0.7	0.09	0.67	0.8	0.67	-0.8
Retained Earnings	0.24	0.09	-0.06	0.0	-0.2	0.61	0.05	0.45	-0.16	-0.18	-0.26		-0.2	0.35	-0.21	-0.31	-0.03	0.03	0.35	-0.27	-0.09	0.29	0.05	0.0	0.05	0.21
Accounts Payable	-0.41	0.76	-0.86	0.55	0.84	0.63	-0.65	0.54	0.94	0.85	-0.81	-0.2		0.59	0.36	0.89	0.8	-0.88	0.59	0.95	-0.37	-0.12	-0.71	-0.83	-0.71	0.85
Cash	-0.55	0.82	-0.51	0.9	0.82	0.72	-0.44	0.26	0.64	0.82	-0.89	0.35	0.59		0.54	0.59	0.68	-0.52	1.0	0.62	-0.82	-0.41	-0.44	-0.44	-0.44	0.7
Non Current Assets Total	-0.58	0.73	0.07	0.6	0.64	0.01	0.14	-0.34	0.6	0.65	-0.27	-0.21	0.36	0.54		0.66	0.51	0.03	0.54	0.55	-0.37	-0.78	-0.05	0.15	-0.05	0.41
Non Currrent Assets Other	-0.53	0.86	-0.62	0.58	0.87	0.44	-0.5	0.26	0.95	0.88	-0.68	-0.31	0.89	0.59	0.66		0.67	-0.65	0.59	0.97	-0.34	-0.36	-0.56	-0.58	-0.56	0.77
Other Assets	-0.45	0.72	-0.61	0.63	0.79	0.55	-0.36	0.37	0.84	0.79	-0.73	-0.03	0.8	0.68	0.51	0.67		-0.64	0.68	0.74	-0.5	-0.28	-0.53	-0.56	-0.53	0.81
Long Term Debt	0.3	-0.52	0.98	-0.45	-0.69	-0.74	0.86	-0.73	-0.72	-0.7	0.85	0.03	-0.88	-0.52	0.03	-0.65	-0.64		-0.52	-0.76	0.41	-0.24	0.79	0.99	0.79	-0.73
Cash And Short Term Investments	-0.55	0.82	-0.51	0.9	0.82	0.72	-0.44	0.26	0.64	0.82	-0.89	0.35	0.59	1.0	0.54	0.59	0.68	-0.52		0.62	-0.82	-0.41	-0.44	-0.44	-0.44	0.7
Net Receivables	-0.53	0.85	-0.73	0.62	0.89	0.52	-0.56	0.34	0.95	0.91	-0.76	-0.27	0.95	0.62	0.55	0.97	0.74	-0.76	0.62		-0.39	-0.3	-0.62	-0.7	-0.62	0.78
Good Will	0.61	-0.47	0.35	-0.93	-0.74	-0.37	0.43	0.06	-0.33	-0.72	0.7	-0.09	-0.37	-0.82	-0.37	-0.34	-0.5	0.41	-0.82	-0.39		0.48	0.29	0.33	0.29	-0.3
Common Stock Total Equity	0.51	-0.44	-0.3	-0.59	-0.49	0.26	-0.28	0.63	-0.26	-0.48	0.09	0.29	-0.12	-0.41	-0.78	-0.36	-0.28	-0.24	-0.41	-0.3	0.48		-0.17	-0.33	-0.17	-0.04
Short Term Investments	0.33	-0.45	0.78	-0.36	-0.56	-0.6	0.59	-0.57	-0.58	-0.56	0.67	0.05	-0.71	-0.44	-0.05	-0.56	-0.53	0.79	-0.44	-0.62	0.29	-0.17		0.75	1.0	-0.6
Non Current Liabilities Total	0.21	-0.43	0.99	-0.36	-0.6	-0.73	0.85	-0.77	-0.65	-0.61	0.8	0.0	-0.83	-0.44	0.15	-0.58	-0.56	0.99	-0.44	-0.7	0.33	-0.33	0.75		0.75	-0.67
Inventory	0.33	-0.45	0.78	-0.36	-0.56	-0.6	0.59	-0.57	-0.59	-0.57	0.67	0.05	-0.71	-0.44	-0.05	-0.56	-0.53	0.79	-0.44	-0.62	0.29	-0.17	1.0	0.75		-0.6
Other Current Assets	-0.27	0.82	-0.72	0.48	0.71	0.8	-0.52	0.69	0.91	0.73	-0.8	0.21	0.85	0.7	0.41	0.77	0.81	-0.73	0.7	0.78	-0.3	-0.04	-0.6	-0.67	-0.6

Click cells to compare fundamentals

Medpace Holdings Account Relationship Matchups

Medpace Holdings balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	37.7M	37.7M	33.7M	31.8M	32.0M	28.7M
Total Assets	1.4B	1.7B	1.4B	1.7B	2.1B	1.4B
Short Long Term Debt Total	115.1M	131.0M	188.9M	142.1M	126.2M	167.3M
Other Current Liab	157.9M	186.9M	238.4M	333.4M	1.1B	1.1B
Total Current Liabilities	440.1M	557.2M	803.5M	925.1M	1.1B	1.2B
Total Stockholder Equity	805.8M	952.9M	386.4M	559.0M	825.5M	677.5M
Other Liab	28.6M	29.6M	18.8M	23.8M	21.4M	20.0M
Net Tangible Assets	9.5M	96.9M	249.2M	(314.0M)	(361.1M)	(379.2M)
Property Plant And Equipment Net	198.8M	222.7M	248.9M	265.4M	252.3M	150.8M
Current Deferred Revenue	255.7M	344.6M	462.7M	559.9M	643.8M	676.0M
Net Debt	(162.6M)	(330.3M)	160.6M	(103.3M)	(543.2M)	(516.0M)
Retained Earnings	115.2M	235.0M	(359.8M)	(221.6M)	8.2M	8.6M
Accounts Payable	26.6M	25.7M	33.1M	31.9M	32.5M	23.1M
Cash	277.8M	461.3M	28.3M	245.4M	669.4M	702.9M
Non Current Assets Total	917.0M	969.0M	1.0B	1.1B	1.1B	1.0B
Non Currrent Assets Other	8.8M	17.4M	21.1M	25.0M	22.3M	13.1M
Other Assets	9.9M	123.1M	42.6M	69.2M	79.6M	83.6M
Cash And Short Term Investments	277.8M	461.3M	28.3M	245.4M	669.4M	702.9M
Net Receivables	161.0M	186.4M	253.4M	298.4M	296.4M	177.8M
Liabilities And Stockholders Equity	1.4B	1.7B	1.4B	1.7B	2.1B	1.4B
Non Current Liabilities Total	144.8M	149.8M	162.6M	172.7M	170.8M	178.0M
Other Current Assets	69.8M	86.4M	52.3M	50.0M	63.4M	43.4M
Other Stockholder Equity	690.3M	722.4M	758.3M	790.4M	831.8M	719.1M
Total Liab	584.9M	707.0M	966.1M	1.1B	1.3B	750.7M
Deferred Long Term Liab	12.8M	13.6M	1.1M	1.1M	1.2M	1.2M
Property Plant And Equipment Gross	198.8M	222.7M	248.9M	344.8M	351.1M	368.7M
Total Current Assets	473.7M	690.9M	334.0M	593.8M	1.0B	1.1B
Accumulated Other Comprehensive Income	(131K)	(4.8M)	(12.4M)	(10.1M)	(14.7M)	(14.0M)
Short Term Debt	134.4M	159.3M	69.3M	293.0M	336.9M	353.8M
Intangible Assets	46.5M	41.4M	38.0M	35.8M	34.4M	32.6M
Property Plant Equipment	99.4M	85.0M	93.2M	109.8M	126.3M	74.3M
Capital Surpluse	666.6M	695.9M	727.9M	770.8M	886.4M	714.1M

Pair Trading with Medpace Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medpace Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving together with Medpace Stock

0.79	A	Agilent Technologies Earnings Call This Week	Pair Corr
0.63	ME	23Andme Holding	Pair Corr

Moving against Medpace Stock

0.32

VALN

Valneva SE ADR

Pair Corr

The ability to find closely correlated positions to Medpace Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medpace Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medpace Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medpace Holdings to buy it.

The correlation of Medpace Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medpace Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medpace Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Medpace Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Medpace Stock Analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medpace Historical Balance Sheet

Medpace Holdings Inventory

0.86

About Medpace Balance Sheet Analysis

Medpace Holdings Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Medpace Holdings balance sheet Correlations

Medpace Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medpace Holdings balance sheet Accounts

Pair Trading with Medpace Holdings

Moving together with Medpace Stock

Moving against Medpace Stock

Additional Tools for Medpace Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Current Deferred Revenue	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Inventory	+ 1.0	Short Term Investments
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Non Current Liabilities Total	+ 0.99	Long Term Debt
Long Term Debt	+ 0.98	Short Long Term Debt Total

Good Will	- 0.93	Other Current Liab
Cash And Short Term Investments	- 0.89	Net Debt
Cash	- 0.89	Net Debt
Long Term Debt	- 0.88	Accounts Payable
Net Debt	- 0.87	Total Stockholder Equity
Accounts Payable	- 0.86	Short Long Term Debt Total